PinkDx raised $5M in additional Series A funding led by Catalio Capital Management to advance its first test for diagnosing potential gynecologic cancer.
Amount Raised
$5 Million
Round Type
Series A
IndianapolisBiotechnologyInvestors
Description
PinkDx, based in Daly City, CA, has secured an additional $5M in Series A funding to enhance its diagnostic test for women potentially facing gynecologic cancer. This round was led by Catalio Capital Management, with participation from several new investors and existing backers.
Quick answer
PinkDx raised $5 Million in a Series A round, dated January 24, 2025. Investors: The Production Board, Mountain Group Partners, Byers Capital, Mayo Clinic, Blue Venture Fund, Sandbox Clinical Ventures, Bevc and Catalio Capital Management. PinkDx is based in Indianapolis, Indiana, United States.
- How much did PinkDx raise?
- PinkDx raised $5 Million in a Series A round on January 24, 2025.
- Who invested in PinkDx?
- The Production Board, Mountain Group Partners, Byers Capital, Mayo Clinic, Blue Venture Fund, Sandbox Clinical Ventures, Bevc and Catalio Capital Management are named as investors in this round.
- What does PinkDx do?
- PinkDx is an early-stage company focused on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and providing answers that have an immediate, positive..
- Where is PinkDx based and how big is it?
- PinkDx is based in Indianapolis, Indiana, United States. Fundz records about 18 employees.
- Who are the decision-makers at PinkDx?
- Fundz holds 1 contact at PinkDx. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as PinkDx that raised within 45 days of this round, from Fundz verified event records.
- Imbria Pharmaceuticals raised $59M on March 10, 2025.
- Incannex Healthcare raised $12M on March 10, 2025.
- NeOnc Technologies raised $10M on March 10, 2025.
- Acurx Pharmaceuticals raised $3.4M (Seed) on March 10, 2025.
- Lila Sciences raised $200M (Seed) on March 10, 2025.
- Phantom Neuro raised $12M on March 7, 2025.
Who to call at PinkDx, and when
A new round usually means PinkDx is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PinkDx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PinkDx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PinkDx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PinkDx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPinkDx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.